Ditchcarbon
  • Contact
  1. Organizations
  2. Chiron, Corp.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 days ago

Chiron, Corp.

Company website

Chiron, Corp., a leading player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has achieved significant milestones, including advancements in therapeutic solutions and innovative drug development. Chiron, Corp. specialises in biopharmaceuticals, focusing on unique treatments for rare diseases and complex health conditions. Their core products are distinguished by cutting-edge research and a commitment to improving patient outcomes. With a strong market position, Chiron, Corp. has garnered recognition for its contributions to the industry, including partnerships with major healthcare institutions and a robust pipeline of promising therapies. The company continues to push the boundaries of science, making a meaningful impact in the lives of patients worldwide.

DitchCarbon Score

How does Chiron, Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Chiron, Corp.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Chiron, Corp.'s reported carbon emissions

Inherited from Novartis AG

Chiron, Corp., headquartered in the US, currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is part of a corporate family relationship with Novartis AG, from which it inherits climate commitments and initiatives. Chiron's climate strategy is aligned with Novartis AG's sustainability goals, which include various initiatives such as the Science Based Targets initiative (SBTi), CDP, RE100, and the Climate Pledge. These initiatives aim to drive significant reductions in greenhouse gas emissions across the organisation. As a merged entity, Chiron benefits from Novartis AG's established climate commitments, although specific reduction targets for Chiron itself have not been disclosed. The cascading of data and initiatives from Novartis AG indicates a commitment to addressing climate change, although the exact scope of emissions (Scope 1, 2, or 3) and specific reduction achievements remain unspecified. In summary, while Chiron, Corp. does not provide direct emissions data, it is positioned within a framework of robust climate commitments inherited from Novartis AG, reflecting a broader industry trend towards sustainability and emissions reduction.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020112012201320142015201620172018201920202021202220232024
Scope 1
583,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
922,000,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chiron, Corp.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chiron, Corp. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chiron, Corp. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy